Jonathan Milner is a scientist, entrepreneur, and investor dedicated to advancing life sciences and supporting UK startups. Currently, they serve as the CEO of bit.bio, focusing on revolutionary cell programming technology. Milner founded Abcam, transforming it into a global enterprise valued at over $5bn. Their extensive involvement in the life sciences sector includes investing in and mentoring more than 80 startups and co-founding the Milner Therapeutics Institute at the University of Cambridge. Milner holds a Ph.D. in Molecular Genetics from the University of Leicester and has conducted postdoctoral research at the University of Bath and the University of Cambridge.
Location
Cambridge, United Kingdom
This person is not in the org chart
This person is not in any teams
This person is not in any offices